Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 18Lymphoma 9Sarcoma 8Nausea 5Vomiting 4Lymphoma, Non-Hodgkin 4Carcinoma, Hepatocellular 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Osteosarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1Peritoneal Neoplasms 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gastrinoma × Doxorubicin × Clear all
NCT00730483 2017-08-25

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

Yale University

Phase NA Terminated
13 enrolled 5 charts
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡